{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:14:28Z","timestamp":1793823268881,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Existing research suggests that the human immune system and immune cells are involved in the pathogenesis of nephrotic syndrome, but there is still a lack of direct evidence. This study tried to analyze the profiling of immune cells in the peripheral blood of steroid-sensitive nephrotic syndrome (SSNS) patients and steroid-resistant nephrotic syndrome (SRNS) patients before and after standard steroid treatment to clarify the immunological mechanism of nephrotic syndrome patients. The number and proportion of CD4\u2009+\u2009T cells in patients with nephrotic syndrome remained unchanged. However, there is an imbalance of Th1 and Th2 and an excessive increase of Th17 cells. The number of CD8\u2009+\u2009T cells and the number of effector CD8\u2009+\u2009T cells in them increased significantly, but only in SSNS, the number of activated CD8\u2009+\u2009T cells increased, and the number of activated T<jats:sub>reg<\/jats:sub>cells decreased significantly. Nephrotic syndrome patients also have B cell disorder, and it is more prominent in SSNS patients. Compared with the normal control, only the number of B cells and plasmablast in SSNS patients increased significantly (Z\u2009=\u2009\u2212 2.20,<jats:italic>P<\/jats:italic>\u2009=\u20090.028). This study also observed that transitional B cells decreased in both SSNS and SRNS patients, but SSNS patients' decrease was lower than in SRNS patients. Compared with normal controls, monocytes in patients with nephrotic syndrome decreased significantly. The main reason was that Non-classical Monocyte decreased, while Classical Monocyte increased slightly. The total number of NK cells did not change, but the internal cell subgroups' composition occurred. Changes, realized as CD56hi NK cells increased, CD56low NK cells decreased; and the above trend is more evident in SSNS patients. Patients with nephrotic syndrome have immune disorders, including T cells, B cells, Monocytes, and NK cells. It can be confirmed that immune factors are involved in the pathogenesis of the nephrotic syndrome.<\/jats:p>","DOI":"10.1038\/s41598-021-92573-6","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T10:02:49Z","timestamp":1624356169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The immune cell landscape of peripheral blood mononuclear cells from PNS patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Qing","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"92573_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1542\/pir.23-7-237","volume":"23","author":"KS Roth","year":"2002","unstructured":"Roth, K. S., Amaker, B. H. & Chan, J. C. Nephrotic syndrome: pathogenesis and management. Pediatr Rev 23, 237\u2013248 (2002).","journal-title":"Pediatr Rev"},{"key":"92573_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone, D. G., Iijima, K. & Parekh, R. Idiopathic nephrotic syndrome in children. Lancet 392, 61\u201374 (2018).","journal-title":"Lancet"},{"key":"92573_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/BF02724390","volume":"69","author":"S Banerjee","year":"2002","unstructured":"Banerjee, S. Steroid resistant nephrotic syndrome. Indian J. Pediatr. 69, 1065\u20131069 (2002).","journal-title":"Indian J. Pediatr."},{"key":"92573_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub, R. J. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2, 556\u2013560 (1974).","journal-title":"Lancet"},{"key":"92573_CR5","doi-asserted-by":"crossref","unstructured":"Saleem, M. A. & Kobayashi, Y. Cell biology and genetics of minimal change disease. F1000Res 5 (2016).","DOI":"10.12688\/f1000research.7300.1"},{"key":"92573_CR6","doi-asserted-by":"crossref","unstructured":"M, C. et al. B cell phenotype in pediatric idiopathic nephrotic syndrome. 34, 177\u2013181 (2019).","DOI":"10.1007\/s00467-018-4095-z"},{"key":"92573_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00467-018-4166-1","volume":"35","author":"K Kamei","year":"2020","unstructured":"Kamei, K. et al. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children. Pediatr. Nephrol. 35, 17\u201324 (2020).","journal-title":"Pediatr. Nephrol."},{"key":"92573_CR8","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1681\/ASN.2015050523","volume":"27","author":"M Colucci","year":"2016","unstructured":"Colucci, M. et al. B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome. J. Am. Soc. Nephrol. 27, 1811\u20131822 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"92573_CR9","first-page":"1263","volume":"370","author":"A Greka","year":"2014","unstructured":"Greka, A., Weins, A. & Mundel, P. Abatacept in B7-1-positive proteinuric kidney disease. N. Engl. J. Med. 370, 1263\u20131266 (2014).","journal-title":"N. Engl. J. Med."},{"key":"92573_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ndt\/6.3.155","volume":"6","author":"R Peces","year":"1991","unstructured":"Peces, R., S\u00e1nchez, L., Gorostidi, M. & Alvarez, J. Minimal change nephrotic syndrome associated with Hodgkin\u2019s lymphoma. Nephrol. Dial. Transplant 6, 155\u2013158 (1991).","journal-title":"Nephrol. Dial. Transplant"},{"key":"92573_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/ndt\/gfh615","volume":"20","author":"A Karras","year":"2005","unstructured":"Karras, A., de Montpreville, V., Fakhouri, F., Gr\u00fcnfeld, J. P. & Lesavre, P. Renal and thymic pathology in thymoma-associated nephropathy: Report of 21 cases and review of the literature. Nephrol. Dial. Transplant 20, 1075\u20131082 (2005).","journal-title":"Nephrol. Dial. Transplant"},{"key":"92573_CR12","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","volume":"69","author":"V Audard","year":"2006","unstructured":"Audard, V. et al. Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: Report of 21 cases and review of the literature. Kidney Int. 69, 2251\u20132260 (2006).","journal-title":"Kidney Int."},{"key":"92573_CR13","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.4049\/jimmunol.162.12.7080","volume":"162","author":"MR Wills","year":"1999","unstructured":"Wills, M. R. et al. Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J. Immunol. 162, 7080\u20137087 (1999).","journal-title":"J. Immunol."},{"key":"92573_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/PL00013437","volume":"14","author":"J Stachowski","year":"2000","unstructured":"Stachowski, J. et al. Th1\/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome. Pediatr. Nephrol. 14, 779\u2013785 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"92573_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000350161","volume":"37","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. The role of Th17\/IL-17 in the pathogenesis of primary nephrotic syndrome in children. Kidney Blood Press. Res. 37, 332\u2013345 (2013).","journal-title":"Kidney Blood Press. Res."},{"key":"92573_CR16","doi-asserted-by":"crossref","unstructured":"Mohamed, E. H., Abdel-Aziz Baiomy, A., Ibrahim, Z. S. & Soliman, M. M. Modulatory effects of levamisole and garlic oil on the immune response of Wistar rats: Biochemical, immunohistochemical, molecular and immunological study. Mol. Med. Rep. 14, 2755\u20132763 (2016).","DOI":"10.3892\/mmr.2016.5551"},{"key":"92573_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.trsl.2015.04.013","volume":"166","author":"SM Kim","year":"2015","unstructured":"Kim, S. M. et al. Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression. Transl. Res. 166, 375\u2013383 (2015).","journal-title":"Transl. Res."},{"key":"92573_CR18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/TP.0b013e31819d2032","volume":"87","author":"A Demirkiran","year":"2009","unstructured":"Demirkiran, A. et al. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. Transplantation 87, 1062\u20131068 (2009).","journal-title":"Transplantation"},{"key":"92573_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s10157-010-0330-z","volume":"14","author":"T Kanai","year":"2010","unstructured":"Kanai, T. et al. Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome. Clin. Exp. Nephrol. 14, 578\u2013583 (2010).","journal-title":"Clin. Exp. Nephrol."},{"key":"92573_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","volume":"139","author":"LL Liu","year":"2011","unstructured":"Liu, L. L. et al. Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin. Immunol. 139, 314\u2013320 (2011).","journal-title":"Clin. Immunol."},{"key":"92573_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/eji.1830250604","volume":"25","author":"H Kimata","year":"1995","unstructured":"Kimata, H., Fujimoto, M. & Furusho, K. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur. J. Immunol. 25, 1497\u20131501 (1995).","journal-title":"Eur. J. Immunol."},{"key":"92573_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10157-016-1313-5","volume":"21","author":"K Iijima","year":"2017","unstructured":"Iijima, K., Sako, M. & Nozu, K. Rituximab for nephrotic syndrome in children. Clin. Exp. Nephrol. 21, 193\u2013202 (2017).","journal-title":"Clin. Exp. Nephrol."},{"key":"92573_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli, M., Massella, L., Ruggiero, B. & Emma, F. Minimal change disease. Clin. J. Am. Soc. Nephrol. 12, 332\u2013345 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"92573_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.kint.2017.01.012","volume":"92","author":"M Rosenzwajg","year":"2017","unstructured":"Rosenzwajg, M. et al. B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab. Kidney Int. 92, 227\u2013237 (2017).","journal-title":"Kidney Int."},{"key":"92573_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: Origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"92573_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","volume":"8","author":"IM Dambuza","year":"2017","unstructured":"Dambuza, I. M. et al. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease. Nat. Commun. 8, 719 (2017).","journal-title":"Nat. Commun."},{"key":"92573_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221\u2013241 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"92573_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","volume":"45","author":"L Mesin","year":"2016","unstructured":"Mesin, L., Ersching, J. & Victora, G. D. Germinal center B cell dynamics. Immunity 45, 471\u2013482 (2016).","journal-title":"Immunity"},{"key":"92573_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4939-1161-5_4","volume":"1190","author":"A de Masson","year":"2014","unstructured":"de Masson, A., Le Buanec, H. & Bouaziz, J. D. Purification and immunophenotypic characterization of human B cells with regulatory functions. Methods Mol. Biol. 1190, 45\u201352 (2014).","journal-title":"Methods Mol. Biol."},{"key":"92573_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jaut.2011.01.005","volume":"36","author":"S Lemoine","year":"2011","unstructured":"Lemoine, S., Morva, A., Youinou, P. & Jamin, C. Human T cells induce their own regulation through activation of B cells. J. Autoimmun. 36, 228\u2013238 (2011).","journal-title":"J. Autoimmun."},{"key":"92573_CR31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.jaci.2015.09.014","volume":"137","author":"Q Simon","year":"2016","unstructured":"Simon, Q. et al. In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles. J. Allergy Clin. Immunol. 137, 1577-1584.e1510 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"92573_CR32","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood.V74.7.2527.2527","volume":"74","author":"B Passlick","year":"1989","unstructured":"Passlick, B., Flieger, D. & Ziegler-Heitbrock, H. W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527\u20132534 (1989).","journal-title":"Blood"},{"key":"92573_CR33","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.4049\/jimmunol.1601281","volume":"198","author":"M Chimen","year":"2017","unstructured":"Chimen, M. et al. Monocyte subsets coregulate inflammatory responses by integrated signaling through TNF and IL-6 at the endothelial cell interface. J. Immunol. 198, 2834\u20132843 (2017).","journal-title":"J. Immunol."},{"key":"92573_CR34","doi-asserted-by":"crossref","unstructured":"Boyette, L. B. et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One 12, e0176460 (2017).","DOI":"10.1371\/journal.pone.0176460"},{"key":"92573_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri2073","volume":"7","author":"HG Ljunggren","year":"2007","unstructured":"Ljunggren, H. G. & Malmberg, K. J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7, 329\u2013339 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"92573_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","volume":"19","author":"N Shimasaki","year":"2020","unstructured":"Shimasaki, N., Jain, A. & Campana, D. NK cells for cancer immunotherapy. Nat. Rev. Drug Discov. 19, 200\u2013218 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"92573_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri3158","volume":"12","author":"HT Maecker","year":"2012","unstructured":"Maecker, H. T., McCoy, J. P. & Nussenblatt, R. Standardizing immunophenotyping for the Human Immunology Project. Nat. Rev. Immunol. 12, 191\u2013200 (2012).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92573-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T04:32:18Z","timestamp":1672547538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92573-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92573"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92573-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13083"}}